VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,050,115 | -10.9% | 150,506 | -0.3% | 2.57% | -6.6% |
| Q2 2023 | $4,545,283 | -6.2% | 150,956 | +0.8% | 2.75% | -17.1% |
| Q1 2023 | $4,844,604 | +8.8% | 149,756 | -3.6% | 3.32% | +8.0% |
| Q4 2022 | $4,452,501 | +58.3% | 155,356 | +33.2% | 3.07% | +6.8% |
| Q3 2022 | $2,813,000 | -13.0% | 116,610 | -1.2% | 2.88% | +35.7% |
| Q2 2022 | $3,232,000 | -24.9% | 118,060 | +5.3% | 2.12% | +4.1% |
| Q1 2022 | $4,301,000 | +39.3% | 112,160 | +16.3% | 2.04% | +51.2% |
| Q4 2021 | $3,088,000 | +4.1% | 96,410 | -4.2% | 1.35% | -4.1% |
| Q3 2021 | $2,965,000 | -23.9% | 100,610 | -12.2% | 1.40% | -22.1% |
| Q2 2021 | $3,895,000 | +17.7% | 114,625 | +12.9% | 1.80% | +8.7% |
| Q1 2021 | $3,310,000 | -5.0% | 101,550 | +4.9% | 1.66% | -12.5% |
| Q4 2020 | $3,485,000 | – | 96,800 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |